Skip to content

Cohort study of Inpatients with Cerebral Small Vessel Disease

Cohort study of Inpatients with Cerebral Small Vessel Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058443
Enrollment
Unknown
Registered
2022-04-09
Start date
2022-04-20
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral small vessel disease

Interventions

None listed

Sponsors

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Inpatients of Tongji Hospital; 2. Age > 18 years; 3. All patients underwent MRI (T1WI, T2WI, FLAIR) + DWI + SWI. Lesions on MRI can be inferred as "presumed cerebral small vascular origin"; 4. MRI of patients meet criteria I: The total WMH Fazekas score >= 3, or number of lacune >= 1; Or criteria II: Total WMH Fazekas score = 3; Or criterion III: or recent subcortical small infarctions appears on DWI; 5. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Significantly limited independent living ability, and unable to cooperate to complete the inspection; 2. Cerebral hemorrhage, subarachnoid hemorrhage, intracranial space-occupying lesions and other diseases at present; 3. Acute ischemic stroke with infarction diameter greater than 2cm, or severe stroke at baseline (NIHSS score = 15); 4. Severe depression and anxiety; 5. Serious mental disorders such as schizophrenia; 6. Other nonvascular diseases that cause leukoencephalopathy, including CO poisoning, multiple sclerosis and adrenoleukodystrophy; 7. Dementia or cognitive impairment caused by other non vascular causes (such as frontotemporal dementia, Alzheimer's disease, Lewy body dementia, prion protein disease, Parkinson's disease, autoimmune encephalitis, etc.); 8. Serious systemic diseases, such as serious liver and kidney diseases, respiratory diseases, cancer, and severe acute infection; 9. Subjects who can not cooperate with neuropsychological assessment and MRI examination due to obvious hearing or vision impairment, language disorder, claustrophobia, etc.; 10. The expected service life is less than 1 year; 11. Patients who could not be followed up during the study.

Design outcomes

Primary

MeasureTime frame
Demographic data;Past history and risk factors;Family history;Imaging data;Assessment of daily living ability;Overall Cognitive Test and Dementia Assessment;New stroke;New cardiovascular events;Subdomain Cognitive Test;General health assessment;Fatigue assessment;

Countries

China

Contacts

Public ContactWenhao Zhu

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

tianyalinghu@126.com+86 13437196982

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026